Study: CVD risk is higher in normoalbuminuric type 1 diabetes patients with CAN

04/18/2012 | PhysiciansBriefing.com

Normoalbuminuric type 1 diabetes patients with cardiovascular autonomic neuropathy showed higher coronary artery calcium scores as well as higher pulse pressure and subtle impairments of left ventricular systolic and diastolic function than their counterparts without CAN, a study in Diabetes found. The findings suggest that CAN may affect cardiovascular disease risk in patients with normal albumin excretion rates, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA